Active substances
Dextrose + Potassium chloride + Sodium chloride + Sodium citrate
- SFDA 4
SFDA Saudi Arabia — SFDA human drug list
| Trade name | Strength | Form · route | Pack | Public price | Type | Company | Status |
|---|---|---|---|---|---|---|---|
| BABYLYTE | 27.5,2.045,0.980,2.162 g/l,g/l,g/l,g/l | Oral solution · Oral use | 1 Bag | SAR 7.35 | Generic · OTC | Pharmaceutical Solution Industries (PSI) | Valid |
| BABYLYTE | 27.5,2.045,0.980,2.162 g/l,g/l,g/l,g/l | Oral solution · Oral use | 1 Bag | SAR 4.05 | Generic · OTC | Pharmaceutical Solution Industries (PSI) | Valid |
| BABYLYTE | 27.5,2.045,0.980,2.162 g/l,g/l,g/l,g/l | Oral solution · Oral use | 1 Bag | SAR 12.15 | Generic · OTC | Pharmaceutical Solution Industries (PSI) | Valid |
| ORALITE 28GM SACHETS | 20,3.5,2.9,1.5 g,g,g,g | Powder for oral solution · Oral use | 10 Sachet | SAR 12.00 | Generic · OTC | KUWAIT SAUDI PHARMACEUTICAL INDUSTRIES | Valid |
Indications — CHI Daman Drug Formulary
BACTRIAL INFECTIONS OF THE GASTROINTESTINAL TRACT - VIBRIO CHOLERAE, SHIGELLA INFECTIONS , SALMONELLA ENTERICA TYPHI OR PARA-TYPHI, NONTYPHOIDAL SALMONELLA ENTERICA INFECTIONS, CAMPYLOBACTER INFECTIONS; INFECTIOUS DIARRHEA-SUPPORTIVE TREATMENT; TRAVELLER'S DIARRHEA; VIRAL GASTROENTERITIS
Components
Values as published by each source: SFDA human drug list (4-2026, as published by the Council of Health Insurance; indications from the CHI Daman Drug Formulary), Drugs@FDA, EMA medicines data, Health Canada Drug Product Database (Open Government Licence – Canada), CMS NADAC, NHS Drug Tariff Part VIIIA (NHSBSA Copyright, Open Government Licence v3.0), WHO Model List of Essential Medicines (CC BY 3.0 IGO; regrouped by active substance, not created by WHO), EMA PRAC, US FDA safety-related labeling changes and MHRA Drug Safety Update (Open Government Licence v3.0). Sources and reuse. Not a substitute for the official registers or the product information.